Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3

Slides:



Advertisements
Similar presentations
Dots 5 × TABLES MULTIPLICATION.
Advertisements

Dots 5 × TABLES MULTIPLICATION.
Dots 2 × TABLES MULTIPLICATION.
Dots 3 × TABLES MULTIPLICATION.
Dots 6 × TABLES MULTIPLICATION.
Quantitative PCR of CRTAC1 (white columns) and WASF1 (black columns) loci in germ line DNA (A), glomus tumor no. 1 (B), and glomus tumor no. 3 (C) from.
Dots 2 × TABLES MULTIPLICATION.
Dots 4 × TABLES MULTIPLICATION.
Distribution of informative SNPs with LOH (black bars) on each chromosome (rows, oriented p-arm at the bottom and q-arm at the top of each chromosome)
Number of 0.5-Mb windows with chromosome lesions that reached statistical significance across patients in early (BE early and BE instability) and late.
Proportion of responses to each of the six questions for the national Picker survey (black dots) and our study of 385 participants, who were all parents.
Correlation between MRP1 mRNA expression and CF efflux-blocking factors of MK-571 (A) and between MDR1 mRNA expression and Rh123 efflux-blocking factors.
Effect of nucleoside analogues on DNA repair response initiated by 4-HC. Effect of nucleoside analogues on DNA repair response initiated by 4-HC. A, CLL.
Dots 3 × TABLES MULTIPLICATION.
Frequent alterations identified and potential actionability.
A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.
VEGF expression in neoplastic and normal prostate tissue.
Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.
FGFR3 mutation analysis of a selection of urine samples from patients included with an FGFR3-mutant (MT) tumor. FGFR3 mutation analysis of a selection.
Study overview. Study overview. A, Schematic illustrating clinical trial design and the nature and number of tissue specimens available for downstream.
Induction of cytotoxic activity in humanized SCC3 tumor-bearing mice treated with anti-PD-1 antibody. Induction of cytotoxic activity in humanized SCC3.
Somatic mutational rates and survival analysis of IBD-CRC.
High-throughput siRNA screening results and corresponding patient gene expression data for PP2A subunits. High-throughput siRNA screening results and corresponding.
Specific up-regulation and down-regulation of immunomodulatory genes in human breast and colorectal cancers. Specific up-regulation and down-regulation.
FILM protein signature predicts poor survival in nontreated stage-IB lung adenocarcinoma. FILM protein signature predicts poor survival in nontreated stage-IB.
A, unsupervised clustering of all BRCA1 (red), BRCA2 (blue), and sporadic (green) breast tumors of our collection using the regions reported as discriminative.
IGF-IR in human head and neck cancer.
Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.
Supernatants of the positive proliferative responses indicated in Table 1 were analyzed for the presence of IFNγ, tumor necrosis factor-α, IL-2, IL-4,
Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.
Duration of treatment and intervals of radiographic and ctDNA response
Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.
Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer (patient 6). Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer.
Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.
NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.
Heterogeneous effects of fulvestrant were observed between lesions within individuals. Heterogeneous effects of fulvestrant were observed between lesions.
PSMA expression in pre- and posttreatment prostate carcinoma serum.
Reduced klotho expression in pancreatic cancer.
A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.
Effect of CDV on human SF7796 xenografts in vivo.
Free interstitial drug as a function of the initial load of soluble drug, ci0 and the intracellular binding capacity, bc,max. Free interstitial drug as.
Prevalence of germline T790M.
Kaplan–Meier curves for RFS and OS by various marker groups.
Macroscopic observations of the mogamulizumab-induced skin-related AEs
Mean weight change from original weight of (a) BALB/c (b) DBA/2 mice after one (♦) or two (▴) injections of 10 mg/kg and one (▪) or two (×) injections.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Lesions and healthy organs dosimetry.
Efficacy summary for patients with gastric/GEJ adenocarcinoma (part B)
Change in FES uptake in the tumor during fulvestrant treatment.
A, pretreatment CT scan of pelvic lymphadenopathy (identified by white arrow) in 1 patient with documented response to 1α-OH-D2. A, pretreatment CT scan.
Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.
Monocytes from melanoma patients are unresponsive to TLR3 agonists.
ROC analysis of MIC-1 and CA19-9.
A, Selected 4 quantitative imaging features significantly associated with 3 imaging subtypes, including tumor volume, tumor sphericity, tumor homogeneity.
Progastrin staining in colon adenomas and adenocarcinomas.
Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.
The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.
HPLC chromatograms using mobile phase containing CTAB and OSA showing complete separation of: A, phthaloylglutamine and phthaloylisoglutamine authentic.
A summary of the average level of methylation of selected MCA/RDA MICPs by bisulfite-modified genomic sequencing. A summary of the average level of methylation.
Biodistributions 24 hours after injection of different 177Lu-chCE7F(ab′)2 conjugates ( MBq, 13 μg) in tumor-bearing nude mice: effect of the number.
Antigen expression and Breslow thickness.
Cellular pharmacology of F-ara-A and Cl-F-ara-A.
Representative biodistribution pattern of 111In-CMD-193.
Progression and survival analysis.
Detection of E-cadherin fragments in human prostate cancer metastases.
Biopsies of the vaccination site were obtained 48 h after the first vaccination. Biopsies of the vaccination site were obtained 48 h after the first vaccination.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,
Presentation transcript:

Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3 Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3.75) in different tissues. Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3.75) in different tissues. Data for 14 metastases in six patients. Black columns, without nicotinamide and carbogen; dotted columns, with nicotinamide and carbogen. Measurements were not obtained for all metastases (see Table 1). Nishi Gupta et al. Clin Cancer Res 2006;12:3115-3123 ©2006 by American Association for Cancer Research